ComplianceOnline

IDE Early Access: Continued Access


FDA may allow continued enrollment of subjects after the controlled clinical trial under an IDE has been completed in order to allow access to the investigational medical device while the marketing application is being prepared by the sponsor or reviewed by FDA.


Criteria:

  • Public health need or
  • Preliminary evidence that the device will be effective and there are no significant safety concerns